Heterogeneity Between Rat and Calf Peripheral-Type Benzodiazepine Binding Sites: Differential Sensitivity to Triton X-100

References

• Squires R., Braestrup C. Benzodiazepine receptors in rat brain. Nature 1977; 266: 732–734
   PubMed Web of Science ®Google Scholar
• Mohler H., Okada T. Benzodiazepine receptor: demonstration in the central nervous system. Science 1977; 198: 849–851
   PubMed Web of Science ®Google Scholar
• Mohler H., Okada T., Heitz P. H., Ulrich J. Biochemical identification of the site of action of benzodiazepine in brain. Life Sci. 1978; 22: 985–996
   PubMed Web of Science ®Google Scholar
• Benavides J., Quarteronet D., Plouin P. ‐F., Imbault F., Phan T., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. Characterization of peripheral‐type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195, studies in hypertensive patients. Biochem. Pharmacol. 1984; 33: 2467–2472
   PubMed Web of Science ®Google Scholar
• Taniguchi T., Wang J. K. T., Spector S. Properties of [3H]Diazepam binding to rat peritoneal mast cells. Life Sci. 1980; 27: 171–178
   PubMed Web of Science ®Google Scholar
• Fares F., Gavish M. Characterization of peripheral benzodiazepine binding sites in human term placenta. Biochem. Pharmacol. 1986; 35: 227–230
   PubMed Web of Science ®Google Scholar
• Schoemaker H., Bliss M., Yamamura H. I. Specific high affinity saturable binding of [3H]Ro 5–4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur. J. Pharmacol. 1981; 71: 173–178
   PubMed Web of Science ®Google Scholar
• Marangos J. P., Patel J., Rosenberg R. C. Characterization of peripheral‐type benzodiazepine binding sites in brain using [3H]Ro 5–4864. Mol. Pharmacol. 1982; 22: 26–32
   PubMed Web of Science ®Google Scholar
• Benavides J., Quarteronet D., Imbault F., Malgouris A., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. Labeling of “peripheral‐type” benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoqinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem. 1983; 41: 1744–1750
   PubMed Web of Science ®Google Scholar
• Mestre M., Carriot C., Belin A., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Doble A., Le Fur G. Electrophysiological and pharmacological evidence that peripheral‐type benzodiazepine receptors are coupled to calcium channel in the heart. Life Sci. 1984; 36: 391–396
   Web of Science ®Google Scholar
• Le Fur G., Mestre M., Carriot C., Belin A., Renault C., Dubroeucq M. C., Gueremy C., Uzan A. Pharmacology of peripheral type benzodiazepine receptors in the heart. Endocoids. Alan R. Liss, New York 1985; 175
   Google Scholar
• Wang J. K. T., Morgan J. I., Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 753–756
   PubMed Web of Science ®Google Scholar
• Matthew W., Laskin J. D., Zimmerman E. A., Weinstein B., Hsu K. C., Engelhart D. L. Benzodiazepine have high‐affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 3935–3939
   PubMed Web of Science ®Google Scholar
• Pellow S., File S. Behavioral action of Ro 5–4864: a peripheral‐type benzodiazepine. Life Sci. 1984; 35: 229–240
   PubMed Web of Science ®Google Scholar
• Grandison L. Suppression of prolactin secretion by benzodiazepines in vivo. Neuroendocrinol. 1982; 34: 369–373
   PubMed Web of Science ®Google Scholar
• Ritta M. N., Campos M. R., Calandra R. C. Effect of GABA and benzodiazepine on testicular androgen production. Life Sci. 1987; 40: 791–798
   PubMed Web of Science ®Google Scholar
• Bisserbe J. C., Patel J., Eskav R. L. Evidence that the peripheral‐type benzodiazepine receptors ligand Ro 5–4864 inhibits β‐endorphin release from AtT‐20 cells by blockade of voltage‐dependent calcium channels. J. Neurochem. 1986; 47: 1419–1424
   PubMedGoogle Scholar
• Gavish M., Weizman A., Okun F., Youdim M. B.H. Modulatory effects of thyroxine treatment on central and peripheral benzodiazepine receptor in the rat. J. Neurochem. 1986; 47: 1106–1110
   PubMed Web of Science ®Google Scholar
• Gavish M., Weizman A., Okun F., Youdim M. B.H. Modulation of peripheral benzodiazepine binding sites following estradiol treatment. Eur. J. Pharmacol. 1986; 127: 147–151
   PubMed Web of Science ®Google Scholar
• Gavish M., Weizman A., Youdim M. B. H., Okun F. Regulation of central and peripheral benzodiazepine receptors in progesterone‐treated rats. Brain Res. 1987; 409: 386–390
   PubMed Web of Science ®Google Scholar
• Fares F., Bar‐Ami S., Brandes J. M., Gavish M. Gonadotropine‐ and estrogen‐ induced increase of peripheral‐type benzodiazepine binding sites in the hypophyseal‐genital axis of rats. Eur. J. Pharmacol. 1987; 133: 97–102
   PubMed Web of Science ®Google Scholar
• Verma A., Nye J. S., Snyder S. H. Porphyrins are endogenous ligands for mitochondrial (peripheral‐type) benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 2256–2260
   PubMed Web of Science ®Google Scholar
• Awad M., Gavish M. Binding of [3H]Ro 5–4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J. Neurochem. 1987; 49: 1407–1414
   PubMed Web of Science ®Google Scholar
• Bassile A. S., Klein D. C., Skolnick P. Characterization of benzodiazepine receptors in the bovine pineal gland: evidence for the presence of an atypical binding site. Mol. Brain Res. 1986; 1: 127–135
   Google Scholar
• Cymerman V., Pazo S. A., Palacios J. M. Evidence for species differences in “peripheral” benzodiazepine receptors: an autoradiographic study. Neurosci. Lett. 1986; 66: 153–158
   PubMed Web of Science ®Google Scholar
• Awad M., Gavish M. Differential effect of detergents on [3H]Ro 5–4864 and [3H]PK 11195 binding to peripheral‐type benzodiazepine‐binding sites. Life Sci. 1988; 43: 167–175
   PubMed Web of Science ®Google Scholar
• Benavides J., Begassat F., Phan T., Tur C., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist PK 11195, but not of an agonist Ro 5–4864, of the peripheral benzodiazepine receptors. Life Sci. 1984; 35: 1249–1256
   PubMed Web of Science ®Google Scholar
• Le Fur G., Vaucher N., Perrier M. L., Flamier A., Benavides J., Renault C., Dubroeucq M. C., Gueremy C., Uzan A. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]Ro 5–4864 and [3H]PK 11195, by thermodynamic studies. Life Sci. 1983; 33: 449–457
   PubMed Web of Science ®Google Scholar
• Mestre M., Bouetard G., Uzan A., Gueremy C., Renault C., Dubroeucq M. C., Le Fur G. PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog. Eur. J. Pharmacol. 1985; 112: 257–260
   PubMed Web of Science ®Google Scholar
• Benavides J., Manager J., Burgevin M. C., Ferris O., Uzan A., Gueremy C., Renault C., Le Fur G. Characterization of solubilized “peripheral‐type” benzodiazepine binding sites from rat adrenal gland using [3H]PK 11195, an isoqinoline carboxamide derivative. Biochem. Pharmacol. 1985; 34: 167–170
   PubMed Web of Science ®Google Scholar
• Martini C., Giannaccini G., Lucacchini A. solubilization of rat kidney benzodiazepine binding sites. Biochem. Biophy. Acta. 1983; 728: 289–292
   PubMedGoogle Scholar
• Gavish M., Fares F. The effect of freezing and thawing or of detergent treatment on peripheral benzodiazepine binding sites: the possible existence of an endogenous ligand. Eur. J. Pharmacol. 1985; 107: 283–284
   PubMed Web of Science ®Google Scholar